Nemaura Medical Completes Initial Shipment of CGM Devices to UK Licensee
07 déc. 2021 09h00 HE
|
Nemaura Medical, Inc
Sales in UK expected to be followed by launches across major EU territories in 2022 Loughborough, England, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the...
Nemaura Medical to Present at the Benzinga Global Small Cap Conference
30 nov. 2021 08h00 HE
|
Nemaura Medical, Inc
Loughborough, England, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic...
Nemaura Medical Announces Fiscal Second Quarter 2022 Financial Results and Provides Business Update
15 nov. 2021 09h30 HE
|
Nemaura Medical, Inc
Loughborough, England, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical to Present at the Diabetes Technology Society 2021 Conference on November 4, 2021
03 nov. 2021 18h51 HE
|
Nemaura Medical, Inc
Loughborough, England, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic...
Nemaura Medical to Present at the LD Micro Main Event Conference
05 oct. 2021 08h00 HE
|
Nemaura Medical, Inc
Loughborough, England, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic...
Nemaura Medical Launches Beta Version of Its Metabolic Health Program
29 sept. 2021 08h30 HE
|
Nemaura Medical, Inc
MiBoKo, a noninvasive glucose sensor utilizing AI mobile application, addresses a substantial multibillion-dollar market opportunity in healthcare LOUGHBOROUGH, England, Sept. 29, 2021 (GLOBE...
Nemaura Medical Announces Commercial Agreement with UK Licensee
27 sept. 2021 08h00 HE
|
Nemaura Medical, Inc
Nemaura has previously placed order for 200,000 CGMs in anticipation of commercial ramp-up Loughborough, England, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura”...
Nemaura Medical to Present at the Benzinga Healthcare Small Cap Conference
21 sept. 2021 08h30 HE
|
Nemaura Medical, Inc
Loughborough, England, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable...
Nemaura Medical announce Professor Osama Hamdy Joins their Advisory Board
17 sept. 2021 09h05 HE
|
Nemaura Medical, Inc
Loughborough, England, Sept. 17, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference
01 sept. 2021 08h00 HE
|
Nemaura Medical, Inc
Loughborough, England, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable...